Chris Molaro, CEO of Neuroflow and a 2017 MBA graduate of UPenn, and Adam Pardes, COO of Neuroflow and a bioengineering PhD candidate currently on leave from the university, developed the data analytics platform, which analyzes information from wearable devices. The platform is meant to provide clinicians with measures related to a patient’s mental health characteristics, such as stress markers.
“It’s not about replacing clinicians or making a diagnosis in five minutes, but about really trying to understand how someone’s feeling quantitatively rather than by just relying on self-reporting,” Mr. Pardes told The Daily Pennsylvanian.
NeuroFlow, which has eight full-time employees with backgrounds in software engineering, bioengineering, and business, has been deployed at the Children’s Hospital of Philadelphia and several local clinics.
More articles on health IT:
VA considers social, behavioral survey of 10k veterans to predict admissions
Harvard, UChicago among collaborators on NIH data commons project
Mount Sinai researchers develop model to predict patient responses to immunotherapy
